Anti-Anxiety activity of alstonia scholaris LINN. R.Br

Pharmacologyonline

Volumn 3, Issue , 2008, Pages 761-775

  Arulmozhi, S ^a   Mazumder, Papiya Mitra ^b   Kangralkar, Vishnu A ^c   Narayanan, L Sathiya ^a   Thakurdesai, Prasad ^a  

^a BHARATI VIDYAPEETH DEEMED UNIVERSITY   (India)

^b BIRLA INSTITUTE OF TECHNOLOGY   (India)

^c Maratha Mandal Dental College   (India)

Author keywords

Alstonia scholaris; Antianxiety; Behavioural tests

Indexed keywords

ALCOHOL; ALKALOID; ALSTONIA SCHOLARIS EXTRACT; ANXIOLYTIC AGENT; DIAZEPAM; FLAVONOID; SAPONIN; TRITERPENOID;

ANALYTIC METHOD; ANIMAL EXPERIMENT; ANIMAL MODEL; ANXIETY DISORDER; ARTICLE; CONTROLLED STUDY; DRUG DETERMINATION; DRUG EFFICACY; DRUG MECHANISM; FALSE POSITIVE RESULT; MALE; MAZE TEST; MOUSE; NONHUMAN; OPEN FIELD TEST; PHYTOCHEMISTRY; PLANT LEAF; RAT; ROTAROD TEST; SOLVENT EXTRACTION;

EID: 58149218139     PISSN: None     EISSN: 18278620     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Nadkarni A.K. Dr. K.M. Nadkarni's Indian Materia Medica, Vol. 1. Bombay, India: Popular Prakashan.
2. Kirtikar KR, Basu BD. Indian Medicinal Plants, Vol.1. Allahabad, India: Lalit Mohan Basu.
3. Versha P, Ghosh B, Anroop B, Ramanjit M. Antimicrobial activity of Alstonia scholaris leaf extracts. Indian drugs 2003; 40: 412-413.
4. Keawpradub N, Kirby GC, Steele JCP, et al. Antiplasmodial activity of extracts and alkaloids of three Alstonia species from Thailand. Planta Medica 1999; 65: 690-94.
5. Lim-Sylianco CY, Jocano AP, Linn CM. Antimutagenicity of twenty Philippine plants using the micronucleus test in mice. Philippine Journal of Science 1990; 117: 231-235.
6. Iwo MI, Soemardji AA, Retnoningrum DS, et al. Immunostimulating effect of pule (Alstonia scholaris L. R.Br., Apocynaceae) bark extracts. Clin Hemorheol Microcirc 2000; 23: 177-83.
7. Lin SC, Lin CC, Lin YH, et al. The protective effect of Alstonia scholaris R.Br. on hepatotoxin-induced acute liver damage. Am. J. Clin. Med. 1996; 24: 153-64.
8. Saraswathi V, Ramamoorthy N, Subramaniam S, et al. Inhibition of glycolysis and respiration of sarcoma-180 cells by echitamine chloride. Chemotherapy 1998; 44: 198-205.
9. Saraswathi V, Mathuram V, Subramanian S, et al. Modulation of the impaired drug metabolism in sarcoma-180-bearing mice by echitamine chloride. Cancer Biochem Biophys. 1999; 17: 79-88.
10. Arulmozhi.S, Papiya Mitra Mazumder, Purnima Ashok, et al. Pharmacological activities of Alstonia scholaris Linn Apocynaceaee) - A Review. Pharmacognosy Reviews 2007; 1: 163-70.
11. Costall B, Naylor RJ. Behavioural interactions between 5-hydroxytryptophan, neuroleptic agents and 5-HT receptor antagonists in modifying rodent responding to aversive situations. British J. Pharmacol. 1995; 116: 2989-99.
12. OECD Guidelines - "Guidance document on acute oral toxicity testing" (2001) Series on testing and assessment No. 24, Organisation for economic co-operation and development, OECD Environment, health and safety publications, Paris. (www.oecd.org/ehs).
13. Andre Rex, Jorg-Peter Voigt, Christina Gustedt, et al. Anxiolytic-like profile in Wistar, but not Sprague-Dawley rats in the social interaction test. Psychopharmacology 2004; 177: 23-34.
14. Jain NN, Ohal CC, Shroff RH, et al. Clitoria ternatea and the CNS. Pharmacol Biochem Behav 2003; 75: 529-36.
15. 2C receptor blockade. Psychopharmacology 2005; 177: 1-12.
16. Dunham NM, Miya TS. A note on simple apparatus for detecting Neurological deficit in rats and mice. J.Am. pharm. 1957; 46: 208-9.
17. Kulkarni SK. Handbook of Experimental Pharmacology. Delhi, India: Vallabh Prakashan.
18. Prut L, Belzung C. The open field as a paradigm to measure the effects of drugs on anxiety-like behaviors: a review. Eur J Pharmacol 2003; 463: 3-33.
19. Peng W, Hseih M, Lee Y, et al. Anxiolytic effect of seed of Zizipus jujube in mouse models of anxiety. J. Ehtnopharmacol 2000; 72: 434-441.
20. Pellow S, Chopin P, File SE, et al. Validation of open: closed arm entries in an elevated plus-maze as a measure of anxiety in the rat. J. Neurosci Methods 1985; 14: 149-167.
21. Varty GB, Morgan CA, Cohen-Williams ME, et al. The Gerbil Elevated Plus Maze I: Behavioural characterization and pharmacological validation. Neuropsychopharmacol 2002; 27: 357-370.
22. De Angelis L, Bertolissi M, Nardini G, et al. Interaction of caffeine with benzodiazepines: behavioural effects in mice. Arch Int Pharmacodyn Ther 1982; 255: 89-102.
23. Sonavane GS, Sarveiya VP, Kasture VS, et al. Anxiogenic activity of Myristica fragrans seeds. Pharmacol Biochem Behav 2002; 71: 239-44.
24. Crawley JN, Goodwin FK. Preliminary report of a simple animal behaviour for the anxiolytic effects of benzodiazepines. Pharmacol Biochem Behav 1980; 13: 167-170.
25. Imaizumi M, Suzuki T, Machida H, et al. A fully automated apparatus for a light/dark test measuring anxiolytic or anxiogenic effects of drugs in mice. Jpn J Psychopharmacol 1994; 14: 83-91.
26. Thakur VD, Mengi SA. Neuropharmacological profile of Eclipta alba L. Hassk. J Ethnopharmacol 2005; 102: 23-31.
27. Young R, Batkai S, Dukat M, et al. TDIQ (5,6,7,8-tetrahydro-1,3-dioxolo [4,5-g]isoquinoline) exhibits anxiolytic-like activity in a marble-burying assay in mice. Pharmacol Biochem Behav 2006; 84: 62-73.
28. Goel RK, Sigh A, Naidu PS, et al. PASS assisted search and evaluation of some azetidin-2-ones as CNS active agents. J Pharm Pharmaceut Sci 2005; 8: 182-189.
29. Tedeschi RE, Tedeschi DH, Mucha A, et al. Effects of various centrally acting drugs on fighting behaviour of mice. J Pharmacol Exp Ther 1959; 125: 28-34.
30. Bhatacharya SK, Satyan KS. Experimental methods for evaluation of psychotropic agents in rodents: Anti-anxiety agents. Indian J Exp Biol 1997; 35: 565-575.